CG
Charles Garvin
No background info available
Check back soon. More details may be added later.
Partnering listings
Learn more
Riptide Bioscience Inc.
CD206 agonist for tumor microenvironment modulation
Riptide Bioscience presents a novel CD206 agonist that targets tumor-associated macrophages to reverse immune suppression and boost anti-tumor immunity. This technology involves proprietary peptides and a companion diagn...
TechnologyIn developmentCompany
Riptide Bioscience Inc.
Designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment
Riptide Bioscience Inc. has developed advanced antimicrobial peptides, RP556 and RP557, for treating recurrent vulvovaginal candidiasis. These peptides show potent activity against C. acnes with low toxicity, offering a ...
TechnologyIn developmentCompany
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.